Karen is an epidemiologist and modeller, and holds a D.Phil (PhD) in epidemiology from the University of Oxford. She leads the Cancer Research Division at Cancer Council NSW which has 80 staff and students and includes a program of externally awarded grants and an active internal epidemiology group. The focus of the internal program of research, called Pathways to a Cancer-Free Future, is to provide policy-makers with an evidence-base for decision making in cancer control. Karen has led evaluations of new screening approaches for government agencies in several countries and currently leads an NHMRC Centre of Research Excellence in Cervical Cancer Control (C4). Her team’s work underpins the Renewal of the National Cervical Screening Program in Australia, which transitioned to 5-yearly HPV-based screening from in 2017. In collaboration with the Victorian Cytology Service, Karen also initiated Compass, which is Australia’s largest clinical trial to assess cervical screening in an HPV-vaccinated population. She currently has active collaborative modelling grants from the US NIH and WHO to model cervical cancer prevention in the USA and globally. The Pathways program is now focusing on screening for other cancer types, including active projects to quantify the benefits, harms and cost-effectiveness of bowel and breast screening, evaluating screening for Lynch Syndrome, and assessing potential new strategies for PSA testing and lung cancer screening. She is also co-chair of the Steering Group for the Covid-19 and Cancer Global Modelling Consortium (CCGMC.org) which is supported by UICC, the International Agency for Research on Cancer, The International Cancer Screening Network, and the Canadian Partnership against Cancer. The CCGMC aims to quantify the global impact of the pandemic and assist in recovery planning for cancer outcomes.
Abstracts this author is presenting: